Search - tctmd.com

Displaying 341 - 360 of 799

Sort: Relevancy | Date

PRAGUE-12: Surgical Ablation of A-fib During Cardiac Surgery Has Long-term Stroke Benefit

News Conference News HRS 2019

PRAGUE-12: Surgical Ablation of A-fib During Cardiac Surgery Has Long-term Stroke Benefit

May 20, 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

May 16, 2019

Proportionate and Disproportionate MR: A ‘Framework’ for MitraClip and Medical Therapy

News Daily News

Proportionate and Disproportionate MR: A ‘Framework’ for MitraClip and Medical Therapy

May 09, 2019

News Industry News

Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer™

May 06, 2019

News Industry News

New Data Confirms Cardiac Dimensions' Carillon® System Provides Acute Hemodynamic Efficacy In Patients With Functional Mitral Regurgitation

April 26, 2019

FDA Approves Lotus Edge, Ushering Third Device Into US Market

News Daily News

FDA Approves Lotus Edge, Ushering Third Device Into US Market

April 24, 2019

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

News Daily News

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

April 19, 2019

News Daily News

Cardioband Reduces Severe Tricuspid Regurgitation at 6 Months, With Good Safety: TRI-REPAIR

Yael L. Maxwell

April 17, 2019

News Industry News

Neovasc Announces Peer Reviewed Publication in the International Journal of Cardiology Demonstrating that the Neovasc Reducer™ Improves Diastolic Function in patients suffering from severe angina

April 17, 2019

Thromboembolic Risks High in Patients With A-fib, Valvular Disease

News Conference News EHRA 2019

Thromboembolic Risks High in Patients With A-fib, Valvular Disease

March 25, 2019

POET: Oral Antibiotics Continue to Show Good Long-term Results for Endocarditis

News Conference News ACC 2019

POET: Oral Antibiotics Continue to Show Good Long-term Results for Endocarditis

March 18, 2019

COAPT Quality-of-Life Analysis Points to Significant, Sustained Benefits in Health Status With MitraClip

News Conference News ACC 2019

COAPT Quality-of-Life Analysis Points to Significant, Sustained Benefits in Health Status With MitraClip

March 17, 2019

COAPT Echo Substudy in HF Patients With Mitral Regurgitation Offers New Answers, and More Questions

News Conference News ACC 2019

COAPT Echo Substudy in HF Patients With Mitral Regurgitation Offers New Answers, and More Questions

March 17, 2019

FDA Extends MitraClip Indication to Include Functional MR

News Daily News

FDA Extends MitraClip Indication to Include Functional MR

March 14, 2019

News Industry News

FDA approves new indication for valve repair device to treat certain heart failure patients with mitral regurgitation

March 14, 2019

DOACs in Patients With Mitral Stenosis and A-fib: Analysis Suggests a Benefit

News Daily News

DOACs in Patients With Mitral Stenosis and A-fib: Analysis Suggests a Benefit

March 12, 2019

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

News Conference News ACC 2019

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

March 11, 2019

Aortic Stenosis Staging System Validated in Real-World, All-Comers Cohort

News Daily News

Aortic Stenosis Staging System Validated in Real-World, All-Comers Cohort

February 14, 2019

No ‘July Effect’ Observed in Cardiac Surgery

News Conference News STS 2019

No ‘July Effect’ Observed in Cardiac Surgery

Yael L. Maxwell

February 05, 2019

Go With NOACs Over Warfarin in Most Cases: Updated A-fib Guidelines

News Daily News

Go With NOACs Over Warfarin in Most Cases: Updated A-fib Guidelines

January 29, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.